These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1933158)

  • 1. Carcinoma in situ as a prognostic factor for G3pT1 bladder tumours.
    Vicente J; Laguna MP; Duarte D; Algaba F; Chéchile G
    Br J Urol; 1991 Oct; 68(4):380-2. PubMed ID: 1933158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of G3pT1 bladder cancer.
    Jenkins BJ; Nauth-Misir RR; Martin JE; Fowler CG; Hope-Stone HF; Blandy JP
    Br J Urol; 1989 Dec; 64(6):608-10. PubMed ID: 2627635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Superficial tumor of the bladder with associated carcinoma in situ: new occurrences and increase of tumor stage].
    Ojea Calvo A; Nogueira March JL; Figueiredo L; Jamardo D; Benavente J; Castro M
    Actas Urol Esp; 1991; 15(2):139-42. PubMed ID: 1807107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
    Shariat SF; Weizer AZ; Green A; Laucirica R; Frolov A; Wheeler TM; Lerner SP
    Urology; 2000 Nov; 56(5):735-40. PubMed ID: 11068290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk profiles of three clinical types of carcinoma in situ of the bladder.
    Meijer RP; van Onna IE; Kok ET; Bosch R
    BJU Int; 2011 Sep; 108(6):839-43. PubMed ID: 21166747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.
    Mulders PF; Meyden AP; Doesburg WH; Oosterhof GO; Debruyne FM
    Br J Urol; 1994 Apr; 73(4):403-8. PubMed ID: 8199828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial bladder tumours: recurrence and progression.
    Mansoor M; Ali S; Fasihuddin Q; Baloch MU
    J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Superficial carcinoma of the bladder. The pT1 G3 tumor: progression, recurrence, and survival. Treatment].
    Nogueira March JL; Ojea Calvo A; Castro Iglesias AM; Rodríguez Iglesias B
    Actas Urol Esp; 1992 Oct; 16(9):682-90. PubMed ID: 1488920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting recurrence and progression in superficial bladder tumours.
    Kurth KH; Denis L; Bouffioux C; Sylvester R; Debruyne FM; Pavone-Macaluso M; Oosterlinck W
    Eur J Cancer; 1995 Oct; 31A(11):1840-6. PubMed ID: 8541110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.